MAKATUSSIN SYROP - AN OVERVIEW

mavorixafor will increase the stage or impact of codeine by impacting hepatic enzyme CYP2D6 metabolism. Contraindicated. Mavorixafor (a robust CYP2D6 inhibitor) is contraindicated with drugs which have been highly dependent on CYP2D6 for clearance.It will depend on the person having it and what their sexual behaviors are. Despite the fact that they